Upgrades by analysts, especially from major financial institutions like Wells Fargo, can lead to increased investor confidence and a potential rise in stock price. The substantial raise in the price target from $9 to $14 indicates a strong positive outlook for Voyager Therapeutics, which may influence the market sentiment and drive short-term price movement upward.